Stay up to date with our newsletter

Get in touch!

What can we do to help?

I would like to:

Lets start the conversation!

Sign up to our newsletter

View open positions on our Careers page,
or connect with us on Linkedin Twitter Facebook

Thank you!
We will be in touch shortly.

2019.12.03

Global Business Reports interviews Krishna Kanumuri, MD & CEO Sai Life Sciences on the company’s journey of transformation

Krishna Kanumuri, MD & CEO Sai Life Sciences

A recent edition of Global Business Reports (GBR) on India Pharmaceuticals 2019 features the interview with Krishna Kanumuri, MD & CEO of Sai Life Sciences. In the interview, Krishna provides a glimpse of the 20 years of the company, and how it is building itself for the future.
Here’s an excerpt from the interview:
“Sai Life Sciences is undergoing major transformation. Over a period from 2016 to 2020, our company is quadrupling in capacity. This capacity, combined with our proven track record and commitment to building long term partnerships, will no doubt make Sai Life Sciences the partner of choice for large pharma and small biotechs in bringing new medicines to life.”, says CEO Krishna Kanumuri.
Here is the link to read the full interview.

News

2020.06.01

Ensuring manufacturing continuity during the pandemic

Ensuring manufacturing continuity during the pandemic. Together.

‘Make it better together’ is a guiding tenet for how we operate each day. Yet, as it often does during a crisis, a truly collaborative effort during the present pandemic involving all our supply partners, airline & shipping companies, freight forwarders, transporters and our own cross-functional teams, has emphatically reinforced this belief. It has allowed […]
Read more

2020.05.07

Sai Life Sciences joins the global ‘COVID Moonshot’ project

Sai Life Sciences, today announced its collaboration with the COVID Moonshot project that aims to deliver an antiviral drug candidate effective against COVID-19. With an in-kind contribution of a team of Medicinal Chemists and supporting infrastructure, Sai Life Sciences will help synthesize and profile analogues for NCEs and other previously known compounds tested for other […]
Read more

2020.04.11

AAALAC full accreditation

AAALAC International renews full accreditation to Sai Life Sciences for its laboratory animal care and use program

As a validation of our commitment to maintaining the highest standards in animal care and compliance with industry and regulatory guidelines, the Sai Life Sciences discovery facility in Pune recently received a renewed accreditation for its laboratory animal care and use program from AAALAC (Association for the Assessment and Accreditation of Laboratory Animal Care) International. […]
Read more

2020.04.02

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences becomes first India-headquartered company to join Pharmaceutical Supply Chain Initiative (PSCI)

Sai Life Sciences, today announced its induction into the Pharmaceutical Supply Chain Initiative (PSCI) membership as an ‘Associate Member’. Welcoming Sai Life Sciences into its fold, a PSCI spokesperson said, “PSCI and its members are delighted to welcome Sai Life Sciences into membership, PSCI’s first member with its main headquarters in India. We are pleased […]
Read more

2020.04.01

Making sanitizers available during COVID-19 outbreak

Making sanitizers available during COVID-19 outbreak

Over the past few weeks since the outbreak of COVID-19, there’s been a sudden rise in sanitization efforts by various public and private organizations to help arrest the spread of the disease. This, along with efforts of individuals in their own spaces, has created a huge demand for effective alcohol-based sanitizers to aid the sanitization […]
Read more